Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aztreonam for inhalation solution in bronchiectasis
NCT00805025Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Dec 2008
- Primary completion
- Oct 2009
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aztreonam in bronchiectasis, sponsored by Gilead Sciences. Started Dec 2008; status: completed.
02
Drugs
aztreonam
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT00805025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00805025.